Immunogenicity of glycolipids.
Portoukalian
J
J
Laboratory of Tumor Glycobiology, Faculty of Medicine Lyon-Sud, Oullins Cx, France.
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D020274:Autoimmune Diseases of the Nervous System / Q000276:immunology; D001923:Brain Chemistry; D002240:Carbohydrate Sequence; D000939:Epitopes / Q000276:immunology; D005677:G(M1) Ganglioside / Q000276:immunology; D005678:G(M2) Ganglioside / Q000276:immunology; D005699:Galactosylceramides / Q000276:immunology; D005732:Gangliosides / Q000737:chemistry / Q000276:immunology; D005915:Globosides / Q000276:immunology; D006017:Glycolipids / Q000276:immunology*; D006028:Glycosphingolipids / Q000737:chemistry / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D008546:Melanoma, Experimental / Q000276:immunology; D051379:Mice; D008969:Molecular Sequence Data; D015394:Molecular Structure; D019158:N-Acetylneuraminic Acid / Q000276:immunology; D009844:Oligosaccharides / Q000276:immunology; D020361:Paraneoplastic Syndromes, Nervous System / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D001324:Autoantigens; D000939:Epitopes; D005699:Galactosylceramides; D005732:Gangliosides; D005915:Globosides; D006017:Glycolipids; D006028:Glycosphingolipids; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009844:Oligosaccharides; C051917:sulfate-3-glucuronyl paragloboside; D005678:G(M2) Ganglioside; D005677:G(M1) Ganglioside; C026226:ganglioside, GD3; D019158:N-Acetylneuraminic Acid